ENGINEERING OF CYTOLETHAL DISTENDING TOXIN B BY ITS REDUCING IMMUNOGENICITY AND MAINTAINING STABILITY AS A NEW DRUG CANDIDATE FOR TUMOR THERAPY; AN IN SILICO STUDY

Engineering of Cytolethal Distending Toxin B by Its Reducing Immunogenicity and Maintaining Stability as a New Drug Candidate for Tumor Therapy; an In Silico Study

The cytolethal distending toxin (CDT), Haemophilus ducreyi, is one of the bacterial toxins that have recently been considered for targeted therapies, especially in cancer therapies.CDT is an A-B2 exotoxin.Its catalytic subunit (CdtB) is capable of inducing DNA double strand breaks, cell cycle arrest and apoptosis in host eukaryotic cells.The sequen

read more